MA
Mallika Alvala
NMIMS,Hyderabad, National institute of pharmceutical education and research ,hyderabad, Birla institute of technology and science
0000-0003-3770-4725
Employment
-
NMIMS,Hyderabad Assistant Professor2021 - Present
-
National institute of pharmceutical education and research ,hyderabad Faculty2013 - 2020
Education
-
Birla institute of technology and science PhD2010 - 2013
Projects & Funding
Projects & funding information is unavailable.
Publications (66)
- Rational Substitution-Driven Enhancement of Anti-Mycobacterium tuberculosis Activity in a Quinoline–Isonicotinic Acid Hydrazide Hybrid Save
- Confronting Tuberculosis: A Synthetic Quinoline-Isonicotinic Acid Hydrazide Hybrid Compound as a Potent Lead Molecule Against Mycobacterium tuberculosis Save
- Design and synthesis of novel coumarin–benzimidazole hybrids as human galectin-1 inhibitors Save
- Sugar mimics and their probable binding sites: design and synthesis of thiazole linked coumarin-piperazine hybrids as galectin-1 inhibitors Save
- Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins Save
- Design, synthesis and computational studies involving Indole-Coumarin hybrids as galectin-1 inhibitors Save
- Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors Save
- MEMES: Machine learning framework for Enhanced MolEcular Screening Save
- Synthesis and Biological Evaluation of Imidazo[2,1-b]Thiazole based Sulfonyl Piperazines as Novel Carbonic Anhydrase II Inhibitors Save
- Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies Save